Apratastat
CAS: 287405-51-0
Ref. 3D-MLA40551
| 1mg | A consultar | |
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar |
Informação sobre produto
- 3-Thiomorpholinecarboxamide,N-hydroxy-4-[[4-[(4-hydroxy-2-butynyl)oxy]phenyl]sulfonyl]-2,2-dimethyl-, (3S)-(9CI)
- Tmi 005
Apratastat is a drug that inhibits the production of TNF-α, one of the cytokines responsible for inflammation and tissue damage. Apratastat has been shown to be effective in reducing lung damage caused by exposure to smoke or ozone. It also reduces the inflammatory response in skin diseases such as atopic dermatitis and psoriasis. This drug is administered orally and is excreted unchanged in urine. Apratastat has been shown to have biocompatible properties with a long half-life, which makes it suitable for specific treatment of conditions such as chronic obstructive pulmonary disease (COPD).
Propriedades químicas
Consulta técnica sobre: 3D-MLA40551 Apratastat
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
